Found: 6
Select item for more details and to access through your institution.
Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects.
- Published in:
- Physiological Reports, 2019, v. 7, n. 16, p. N.PAG, doi. 10.14814/phy2.14199
- By:
- Publication type:
- Article
Metabolite Profile of Treatment-Naive Metabolic Syndrome Subjects in Relation to Cardiovascular Disease Risk.
- Published in:
- Metabolites (2218-1989), 2021, v. 11, n. 4, p. 236, doi. 10.3390/metabo11040236
- By:
- Publication type:
- Article
Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome.
- Published in:
- NPJ Biofilms & Microbiomes, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41522-020-0127-0
- By:
- Publication type:
- Article
Correlation of plasma metabolites with glucose and lipid fluxes in human insulin resistance.
- Published in:
- Obesity Science & Practice, 2020, v. 6, n. 3, p. 340, doi. 10.1002/osp4.402
- By:
- Publication type:
- Article
Insights Into the Role of the Microbiome in Obesity and Type 2 Diabetes.
- Published in:
- Diabetes Care, 2015, v. 38, n. 1, p. 159, doi. 10.2337/dc14-0769
- By:
- Publication type:
- Article
Novel Proteome Targets Marking Insulin Resistance in Metabolic Syndrome.
- Published in:
- Nutrients, 2024, v. 16, n. 12, p. 1822, doi. 10.3390/nu16121822
- By:
- Publication type:
- Article